Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Johnson & Johnson
Johnson & Johnson
Page 11 of 18
Newsletters
‘HOLDING TO THE MOON’: Yes, the GameStop bulls are back
By
Bernhard Warner
February 25, 2021
Health
J&J’s COVID vaccine could make its global debut as soon as next week
By
David Meyer
February 10, 2021
Health
The AstraZeneca COVID-19 vaccine (and possibly others) are ineffective against the South African variant
By
Jeremy Kahn
February 8, 2021
Health
Johnson & Johnson’s lower-immunity single-dose COVID vaccine might be just what the doctor ordered
By
Kat Eschner
February 1, 2021
Health
Why Europe’s summer COVID vaccination target could still be on track
By
David Meyer
February 1, 2021
Magazine
The companies business leaders admire the most—and are watching closely
By
Matthew Heimer
and
Scott DeCarlo
February 1, 2021
Politics
Johnson & Johnson’s single-dose COVID-19 vaccine is 66% effective, lagging rivals
By
The Associated Press
January 29, 2021
Newsletters
Stocks to watch under a Biden presidency
By
Bernhard Warner
January 26, 2021
Newsletters
Last week’s vaccine-led rally was one for the record books—but is all that good news already priced in?
By
Bernhard Warner
November 16, 2020
Health
The science behind the leading COVID vaccine candidates
By
Sy Mukherjee
November 4, 2020
Newsletters
Not even Big Tech can save investors from the latest markets plunge
By
Bernhard Warner
October 28, 2020
Newsletters
Here’s what could happen to your portfolio in the case of a ‘no deal’ on fiscal stimulus
By
Bernhard Warner
October 21, 2020
Health
As COVID-19 numbers boom and markets tank, Europe’s leaders urge vaccine coordination
By
David Meyer
October 15, 2020
Health
J&J CEO still optimistic COVID-19 vaccine could come as early as this year
By
Robert Hackett
October 14, 2020
Newsletters
Investors pull back on vaccine jitters and earnings woes
By
Bernhard Warner
October 14, 2020
Most Popular
Economy
3 things Trump did in 24 hours to show that he's in control of American business
By
Eva Roytburg
AI
This CEO laid off nearly 80% of his staff because they refused to adopt AI fast enough. 2 years later, he says he'd do...
By
Nick Lichtenberg
Economy
Making billionaires illegal by taxing their wealth wouldn’t even fund the government for a year, budget expert says
By
Nick Lichtenberg